Avadel Pharmaceuticals (AVDL)
(Delayed Data from NSDQ)
$11.15 USD
-0.11 (-0.98%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $11.15 0.00 (0.00%) 7:48 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AVDL 11.15 -0.11(-0.98%)
Will AVDL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AVDL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVDL
Wall Street Analysts See an 81.61% Upside in Avadel (AVDL): Can the Stock Really Move This High?
Surging Earnings Estimates Signal Upside for Avadel (AVDL) Stock
AVDL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think Avadel (AVDL) Could Surge 97.68%: Read This Before Placing a Bet
All You Need to Know About Avadel (AVDL) Rating Upgrade to Buy
Earnings Estimates Moving Higher for Avadel (AVDL): Time to Buy?
Other News for AVDL
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2025 Financial ...
Avadel Pharmaceuticals PLC (AVDL) Announces Upcoming Conference Call for Q2 2025 Financial ...
Avadel Pharmaceuticals PLC (AVDL) Shares Up 3.92% on Jul 21
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | AVDL Stock News
AVDL: HC Wainwright & Co. Announces Buy Rating with $22 Price Target | AVDL Stock News